Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults

NCT03783130 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

NIH

Sponsor class

Conditions

Human Immunodeficiency Virus Prevention
Human Immunodeficiency Virus (HIV)

Interventions

BIOLOGICAL: VRC-HIVRGP096-00-VP
OTHER: Alum Adjuvant

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)